Company: VLDXW
Filing Date: 2025-08-07
Form Type: S-1
Source: 0001641172-25-022475
Chunk: 272

Company: Velo3D, Inc.
Filing Date: 2025-08-07
Form: S-1
Chunk 272
---
 
 tested for impairment                                                                             |     | Yes, per original schedule |     | Yes, may accelerate if impaired      |

If
the 3D printers does not meet the above criteria, the equipment is classified under property and equipment, net.

Revision of Previously Filed Financial Statements

During the second quarter of 2025, the Company discovered the initial research and development and sales and marketing operating expenses for the three months ended March 31, 2025, were incorrectly presented on the unaudited condensed consolidated statement of operations and comprehensive loss. The Company initially reported the research and development expenses under the sales and marketing financial statement line item and the sales and marketing expenses under the research and development financial statement line item in the operating expenses section of the unaudited condensed consolidated statement of operations and comprehensive loss. There was no impact to the total operating expenses, net loss or net loss per share on the unaudited condensed consolidated statement of operations and comprehensive loss for the three months ended March 31, 2025.

The following table reflects the revisions to the previously issued unaudited condensed consolidated statement of operations and comprehensive loss for the three months ended March 31, 2025:

Schedule of Prior Period Adjustments

|                          |     | As Previously Reported            
 Three Months Ended March 31, 2025 |       |     | Adjusted |        |   |     | As Revised |       |
|:-------------------------|:----|:----------------------------------|------:|:----|:---------|-------:|:--|:----|:-----------|------:|
|                          |     | As Previously Reported            |       |     | Adjusted |        |   |     | As Revised |       |
|                          |     | -In thousands                     |       |     |          |        |   |     |            |       |
| Research and development |     | $                                 | 1,212 |     | $        |  1,063 |   |     | $          | 2,275 |
| Selling and marketing    |     | $                                 | 2,275 |     | $        | (1,063 | ) |     | $          | 1,212 |

During the second quarter of 2025, the Company discovered that the cash paid for interest reported under the supplemental disclosure of cash flow information on the unaudited condensed consolidated statement of cash flows for the three months ended March 31, 2025 was incorrect and should have been zero.

| F-60 |